FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3185137851> ?p ?o ?g. }

• W3185137851 abstract "Abstract Background The rapid process of research and development and lack of follow-up time post-vaccination aroused great public concern about the safety profile of COVID-19 vaccine candidates. To provide comprehensive overview of the safety profile of COVID-19 vaccines by using meta-analysis technique. Methods English-language articles and results posted on PubMed, Embase, Web of Science, PMC, official regulatory websites, and post-authorization safety surveillance data were searched through June 12, 2021. Publications disclosing safety data of COVID-19 candidate vaccines in humans were included. A meta-analysis of proportions was performed to estimate the pooled incidence and the pooled rate ratio (RR) of safety outcomes of COVID-19 vaccines using different platforms. Results A total of 87 publications with safety data from clinical trials and post-authorization studies of 19 COVID-19 vaccines on 6 different platforms were included. The pooled rates of local and systemic reactions were significantly lower among inactivated vaccines (23.7%, 21.0%), protein subunit vaccines (33.0%, 22.3%), and DNA vaccines (39.5%, 29.3%), compared to RNA vaccines (89.4%, 83.3%), non-replicating vector vaccines (55.9%, 66.3%), and virus-like particle vaccines (100.0%, 78.9%). Solicited injection-site pain was the most common local reactions, and fatigue and headache were the most common systemic reactions. The frequency of vaccine-related serious adverse events was low (< 0.1%) and balanced between treatment groups. Vaccine platforms and age groups of vaccine recipients accounted for much of the heterogeneity in safety profiles between COVID-19 vaccines. Reporting rates of adverse events from post-authorization observational studies were similar to results from clinical trials. Crude reporting rates of adverse events from post-authorization safety monitoring (passive surveillance) were lower than in clinical trials and varied between countries. Conclusions Available evidence indicates that eligible COVID-19 vaccines have an acceptable short-term safety profile. Additional studies and long-term population-level surveillance are strongly encouraged to further define the safety profile of COVID-19 vaccines." @default.
• W3185137851 created "2021-08-02" @default.
• W3185137851 creator A5013113490 @default.
• W3185137851 creator A5020195459 @default.
• W3185137851 creator A5039848974 @default.
• W3185137851 creator A5045272535 @default.
• W3185137851 creator A5059077734 @default.
• W3185137851 creator A5059259025 @default.
• W3185137851 creator A5068458966 @default.
• W3185137851 creator A5070042023 @default.
• W3185137851 date "2021-07-28" @default.
• W3185137851 modified "2023-10-07" @default.
• W3185137851 title "Evaluation of the safety profile of COVID-19 vaccines: a rapid review" @default.
• W3185137851 cites W2098923148 @default.
• W3185137851 cites W2137591261 @default.
• W3185137851 cites W2146272590 @default.
• W3185137851 cites W2165010366 @default.
• W3185137851 cites W2588681363 @default.
• W3185137851 cites W2616456691 @default.
• W3185137851 cites W2787221426 @default.
• W3185137851 cites W3001897055 @default.
• W3185137851 cites W3027138240 @default.
• W3185137851 cites W3042383115 @default.
• W3185137851 cites W3042833857 @default.
• W3185137851 cites W3043722389 @default.
• W3185137851 cites W3048446898 @default.
• W3185137851 cites W3081892744 @default.
• W3185137851 cites W3083750089 @default.
• W3185137851 cites W3087924281 @default.
• W3185137851 cites W3090717270 @default.
• W3185137851 cites W3091296220 @default.
• W3185137851 cites W3092766467 @default.
• W3185137851 cites W3093367571 @default.
• W3185137851 cites W3093381371 @default.
• W3185137851 cites W3095886982 @default.
• W3185137851 cites W3097433445 @default.
• W3185137851 cites W3100531662 @default.
• W3185137851 cites W3102328262 @default.
• W3185137851 cites W3105219266 @default.
• W3185137851 cites W3111128314 @default.
• W3185137851 cites W3111255098 @default.
• W3185137851 cites W3111590711 @default.
• W3185137851 cites W3111707573 @default.
• W3185137851 cites W3113031614 @default.
• W3185137851 cites W3115068672 @default.
• W3185137851 cites W3119345685 @default.
• W3185137851 cites W3120968995 @default.
• W3185137851 cites W3125405808 @default.
• W3185137851 cites W3127329393 @default.
• W3185137851 cites W3127819257 @default.
• W3185137851 cites W3128551684 @default.
• W3185137851 cites W3128702325 @default.
• W3185137851 cites W3128744331 @default.
• W3185137851 cites W3128853581 @default.
• W3185137851 cites W3130128985 @default.
• W3185137851 cites W3130815000 @default.
• W3185137851 cites W3131688063 @default.
• W3185137851 cites W3131762051 @default.
• W3185137851 cites W3133758295 @default.
• W3185137851 cites W3134483693 @default.
• W3185137851 cites W3135734644 @default.
• W3185137851 cites W3137142873 @default.
• W3185137851 cites W3137281521 @default.
• W3185137851 cites W3139533040 @default.
• W3185137851 cites W3140226555 @default.
• W3185137851 cites W3143074411 @default.
• W3185137851 cites W3147435343 @default.
• W3185137851 cites W3148644681 @default.
• W3185137851 cites W3152102956 @default.
• W3185137851 cites W3152203705 @default.
• W3185137851 cites W3152535389 @default.
• W3185137851 cites W3152687147 @default.
• W3185137851 cites W3153482671 @default.
• W3185137851 cites W3153508314 @default.
• W3185137851 cites W3153677448 @default.
• W3185137851 cites W3154242194 @default.
• W3185137851 cites W3154615775 @default.
• W3185137851 cites W3154849518 @default.
• W3185137851 cites W3154888372 @default.
• W3185137851 cites W3155128665 @default.
• W3185137851 cites W3156211636 @default.
• W3185137851 cites W3156834347 @default.
• W3185137851 cites W3157184104 @default.
• W3185137851 cites W3157488589 @default.
• W3185137851 cites W3157545004 @default.
• W3185137851 cites W3157764873 @default.
• W3185137851 cites W3158373340 @default.
• W3185137851 cites W3158488414 @default.
• W3185137851 cites W3158692149 @default.
• W3185137851 cites W3159001141 @default.
• W3185137851 cites W3159455975 @default.
• W3185137851 cites W3159560235 @default.
• W3185137851 cites W3159703937 @default.
• W3185137851 cites W3159740360 @default.
• W3185137851 cites W3160085354 @default.
• W3185137851 cites W3160693971 @default.
• W3185137851 cites W3161416590 @default.
• W3185137851 cites W3161877876 @default.
• W3185137851 cites W3162025982 @default.
• W3185137851 cites W3164806615 @default.

• next